Cephalosporin Antimicrobial Susceptibility of Neisseria Gonorrhoeae in the United States, 2009–2013
Robert Kirkcaldy, MD, MPH1, John Papp, PhD1, Olusegun Soge, PhD2, Edward W. Hook III, MD3, Carlos del Rio, MD4, Susan Harrington, PhD5, Grace Kubin, PhD6 and Hillard S. Weinstock, MD, MPH7, 1Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 2Neisseria Reference Laboratory, Center for AIDS and STD, Departments of Global Health and Medicine, University of Washington, Seattle, WA, 3Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, 4Rollins School of Public Health, Emory University, Atlanta, GA, 5Cleveland Clinic, Cleveland, OH, 6Laboratory Services Section, Texas Department of State Health Services, Austin, TX, 7Division of STD Prevention/Surveillance and Data Management Branch, Centers for Disease Control and Prevention, Atlanta, GA